Previous close | 10.48 |
Open | 10.65 |
Bid | 10.58 x 100 |
Ask | 10.88 x 100 |
Day's range | 10.11 - 10.96 |
52-week range | 8.25 - 27.03 |
Volume | |
Avg. volume | 132,475 |
Market cap | 74.972M |
Beta (5Y monthly) | 1.57 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Intra-Cellular (ITCI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
The consensus price target hints at a 407.9% upside potential for Precision BioSciences (DTIL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.